Relationship between quality of life (QoL) and clinical outcomes in metastatic castration-resistant prostate cancer (mCRPC) patients after chemotherapy: Results from the AFFIRM study.

被引：1
|
作者：
Miller, Kurt
Cella, David
De Phung
Naidoo, Shevani
Holmstrom, Stefan
Ivanescu, Cristina
Skaltsa, Konstantina
机构：
[1] Charite, Dept Urol, Berlin, Germany
[2] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA
[3] Astellas Pharma Europe, Leiden, Netherlands
[4] Astellas Pharma, Chertsey, England
[5] Quintiles, Hoofddorp, Netherlands
[6] Quintiles, Barcelona, Spain
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 15期
关键词：
D O I：
10.1200/JCO.2016.34.15_suppl.5060
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5060
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Association of alkaline phosphatase (ALP) with clinical outcomes in chemotherapy-naive patients (pts) with metastatic castration-resistant prostate cancer (mCRPC): Results from COU-AA-302
    Yu, Evan Y.
    Saad, Fred
    Londhe, Anil
    Shore, Neal D.
    Van Poppel, Hendrik
    Rathkopf, Dana E.
    Smith, Matthew R.
    Logothetis, Christopher
    De Souza, Paul L.
    Fizazi, Karim
    Mulders, Peter F. A.
    Mainwaring, Paul N.
    Hainsworth, John D.
    Beer, Tomasz M.
    North, Scott A.
    Small, Eric Jay
    Scher, Howard I.
    Griffin, Thomas W.
    Yu, Margaret K.
    Ryan, Charles J.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [42] Effect of abiraterone acetate treatment on the quality of life of patients with metastatic castration-resistant prostate cancer after failure of docetaxel chemotherapy
    Harland, Stephen
    Staffurth, John
    Molina, Arturo
    Hao, Yanni
    Gagnon, Dennis D.
    Sternberg, Cora N.
    Cella, David
    Fizazi, Karim
    Logothetis, Christopher J.
    Kheoh, Thian
    Haqq, Christopher M.
    de Bono, Johann S.
    Scher, Howard I.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (17) : 3648 - 3657
  • [43] Predictors of response to platinum (Pt)-based chemotherapy in metastatic castration-resistant prostate cancer (mCRPC).
    Kilari, Deepak
    Bylow, Kathryn A.
    Berlin, Kathryn E. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (06)
  • [44] Association between health-related quality of life (HRQoL) and clinical outcomes in non-metastatic castration-resistant prostate cancer (M0 CRPC): Results from the PROSPER study.
    Attard, Gerhardt
    Saad, Fred
    Tombal, Bertrand F.
    Hussain, Maha
    Sternberg, Cora N.
    Phung, De
    Naidoo, Shevani
    Modelska, Katharina
    Reisman, Arlene
    Ivanescu, Cristina
    Penson, David F.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [45] Role of chemotherapy in metastatic castration-resistant prostate cancer (mCRPC) treatment: still standard or exception?
    Thomas, Christian
    UROLOGIE, 2023, : 1281 - 1288
  • [46] Is there room for chemotherapy in elderly patients with metastatic castration-resistant prostate cancer (mCRPC) in the era of targeted hormone therapy?
    Müldür E.
    memo - Magazine of European Medical Oncology, 2016, 9 (2) : 93 - 95
  • [47] Clinical outcomes in chemotherapy-naive metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with abiraterone acetate (ABI) stratified by prognosis
    Aviles, C. M.
    Azad, A. A.
    Todenhoefer, T.
    Eigl, B. J.
    Kollmannsberger, C.
    Murray, N.
    Chi, K.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : S486 - S487
  • [48] Plasma circulating tumor DNA (ctDNA) based clinical outcomes in metastatic castration-resistant prostate cancer (mCRPC)
    Kohli, Manish
    Tan, Winston
    Zheng, Tiantian
    Wang, Amy
    Huo, Yelia
    Montesinos, Carlos
    Wong, Calvin
    Du, Pan
    Jia, Shidong
    Yu, Jianjun
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [49] Real-world management of metastatic castration-resistant prostate cancer (mCRPC): A national multicenter cohort study.
    Lavallee, Luke
    Morash, Chris
    Saad, Fred
    Yip, Steven
    Kapoor, Anil
    Kolinsky, Michael Paul
    Pouliot, Frederic
    Antebi, Elie
    Drachenberg, Darrel
    Ferrario, Cristiano
    Gotto, Geoffrey
    Hamilton, Robert James
    Ko, Jenny J.
    Noonan, Krista
    So, Alan
    Malone, Shawn
    Zardan, Anousheh
    Chi, Kim N.
    Hotte, Sebastien J.
    Niazi, Tamim
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
  • [50] Chemotherapy management for unfit patients with metastatic castration-resistant prostate cancer
    U. Anido-Herranz
    N. Fernández-Núñez
    J. Afonso-Afonso
    L. Santomé-Couto
    A. Medina-Colmenero
    O. Fernández-Calvo
    M. Lázaro-Quintela
    S. Vázquez
    Clinical and Translational Oncology, 2019, 21 : 249 - 258
12345